Clinical Trial Update: Pulse ACTH vs. MP for MS [Phase 1]

View source ↗

Summary

Phase 1 trial comparing pulse adrenocorticotropic hormone (ACTH) versus methylprednisolone for multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)
• SOLU-MEDROL (Methylprednisolone sodium succinate)

Snippet

Sponsor: University of Southern California | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED